AbbVie Pre-Tax Income 2010-2024 | ABBV

  • AbbVie annual pre-tax income for 2024 was $3.716B, a 40.54% decline from 2023.
  • AbbVie annual pre-tax income for 2023 was $6.25B, a 53.62% decline from 2022.
  • AbbVie annual pre-tax income for 2022 was $13.477B, a 3.76% increase from 2021.

Historical Chart (TTM)

Click on chart icon to view chart
Click on table icon to view table

Quarterly

Click on chart icon to view chart
Click on table icon to view table

Quarterly - YOY Change

Click on chart icon to view chart
Click on table icon to view table

Annual

Click on chart icon to view chart
Click on table icon to view table

Annual % Change

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B